190 related articles for article (PubMed ID: 10537342)
21. Constitutive nuclear factor kappaB activity is required to elicit interferon-gamma-induced expression of chemokine CXC ligand 9 (CXCL9) and CXCL10 in human tumour cell lines.
Hiroi M; Ohmori Y
Biochem J; 2003 Dec; 376(Pt 2):393-402. PubMed ID: 12946268
[TBL] [Abstract][Full Text] [Related]
22. Lysophosphatidylcholine posttranscriptionally inhibits interferon-gamma-induced IP-10, Mig and I-Tac expression in endothelial cells.
Sheikh AM; Ochi H; Manabe A; Masuda J
Cardiovasc Res; 2005 Jan; 65(1):263-71. PubMed ID: 15621055
[TBL] [Abstract][Full Text] [Related]
23. Treatment with IFN-gamma increases serum levels of Th1 chemokines and decreases those of Th2 chemokines in patients with mycosis fungoides.
Hino R; Shimauchi T; Tokura Y
J Dermatol Sci; 2005 Jun; 38(3):189-95. PubMed ID: 15927812
[TBL] [Abstract][Full Text] [Related]
24. Combined CXC chemokine and interleukin-12 gene transfer enhances antitumor immunity.
Palmer K; Hitt M; Emtage PC; Gyorffy S; Gauldie J
Gene Ther; 2001 Feb; 8(4):282-90. PubMed ID: 11313802
[TBL] [Abstract][Full Text] [Related]
25. Mechanisms of IL-4-mediated suppression of IP-10 gene expression in murine macrophages.
Deng W; Ohmori Y; Hamilton TA
J Immunol; 1994 Sep; 153(5):2130-6. PubMed ID: 8051417
[TBL] [Abstract][Full Text] [Related]
26. Differential expression of retinal pigment epithelium (RPE) IP-10 and interleukin-8.
Elner SG; Delmonte D; Bian ZM; Lukacs NW; Elner VM
Exp Eye Res; 2006 Aug; 83(2):374-9. PubMed ID: 16674942
[TBL] [Abstract][Full Text] [Related]
27. Induction of interferon-inducible protein-10 and monokine induced by interferon-gamma from human endothelial cells infected with Influenza A virus.
Ishiguro N; Takada A; Yoshioka M; Ma X; Kikuta H; Kida H; Kobayashi K
Arch Virol; 2004 Jan; 149(1):17-34. PubMed ID: 14689273
[TBL] [Abstract][Full Text] [Related]
28. A novel role for neutrophils as a source of T cell-recruiting chemokines IP-10 and Mig during the DTH response to HSV-1 antigen.
Molesworth-Kenyon SJ; Oakes JE; Lausch RN
J Leukoc Biol; 2005 Apr; 77(4):552-9. PubMed ID: 15629884
[TBL] [Abstract][Full Text] [Related]
29. Interleukin-18 expression induced by Epstein-Barr virus-infected cells.
Yao L; Setsuda J; Sgadari C; Cherney B; Tosato G
J Leukoc Biol; 2001 May; 69(5):779-84. PubMed ID: 11358987
[TBL] [Abstract][Full Text] [Related]
30. Targeted in vivo expression of IFN-gamma-inducible protein 10 induces specific antitumor activity.
Yang X; Chu Y; Wang Y; Zhang R; Xiong S
J Leukoc Biol; 2006 Dec; 80(6):1434-44. PubMed ID: 16980511
[TBL] [Abstract][Full Text] [Related]
31. Intradermal delivery of IL-12 naked DNA induces systemic NK cell activation and Th1 response in vivo that is independent of endogenous IL-12 production.
Watanabe M; Fenton RG; Wigginton JM; McCormick KL; Volker KM; Fogler WE; Roessler PG; Wiltrout RH
J Immunol; 1999 Aug; 163(4):1943-50. PubMed ID: 10438930
[TBL] [Abstract][Full Text] [Related]
32. Microbial Toll-like receptor ligands differentially regulate CXCL10/IP-10 expression in fibroblasts and mononuclear leukocytes in synergy with IFN-gamma and provide a mechanism for enhanced synovial chemokine levels in septic arthritis.
Proost P; Vynckier AK; Mahieu F; Put W; Grillet B; Struyf S; Wuyts A; Opdenakker G; Van Damme J
Eur J Immunol; 2003 Nov; 33(11):3146-53. PubMed ID: 14579283
[TBL] [Abstract][Full Text] [Related]
33. Keratinocytes from patients with atopic dermatitis and psoriasis show a distinct chemokine production profile in response to T cell-derived cytokines.
Giustizieri ML; Mascia F; Frezzolini A; De Pità O; Chinni LM; Giannetti A; Girolomoni G; Pastore S
J Allergy Clin Immunol; 2001 May; 107(5):871-7. PubMed ID: 11344355
[TBL] [Abstract][Full Text] [Related]
34. Expression of the Mig (CXCL9) gene in murine lung carcinoma cells generated angiogenesis-independent antitumor effects.
Wang YQ; Wada A; Ugai S; Tagawa M
Oncol Rep; 2003; 10(4):909-13. PubMed ID: 12792744
[TBL] [Abstract][Full Text] [Related]
35. Contribution of the CXC chemokines IP-10 and Mig to the antitumor effects of IL-12.
Kanegane C; Sgadari C; Kanegane H; Teruya-Feldstein J; Yao L; Gupta G; Farber JM; Liao F; Liu L; Tosato G
J Leukoc Biol; 1998 Sep; 64(3):384-92. PubMed ID: 9738666
[TBL] [Abstract][Full Text] [Related]
36. Phase I trial of twice-weekly intravenous interleukin 12 in patients with metastatic renal cell cancer or malignant melanoma: ability to maintain IFN-gamma induction is associated with clinical response.
Gollob JA; Mier JW; Veenstra K; McDermott DF; Clancy D; Clancy M; Atkins MB
Clin Cancer Res; 2000 May; 6(5):1678-92. PubMed ID: 10815886
[TBL] [Abstract][Full Text] [Related]
37. Interferon-gamma produced by interleukin-12-activated tumor infiltrating CD8+T cells directly induces apoptosis of mouse hepatocellular carcinoma.
Komita H; Homma S; Saotome H; Zeniya M; Ohno T; Toda G
J Hepatol; 2006 Nov; 45(5):662-72. PubMed ID: 16935390
[TBL] [Abstract][Full Text] [Related]
38. Virus overrides the propensity of human CD40L-activated plasmacytoid dendritic cells to produce Th2 mediators through synergistic induction of IFN-{gamma} and Th1 chemokine production.
Bendriss-Vermare N; Burg S; Kanzler H; Chaperot L; Duhen T; de Bouteiller O; D'agostini M; Bridon JM; Durand I; Sederstrom JM; Chen W; Plumas J; Jacob MC; Liu YJ; Garrone P; Trinchieri G; Caux C; Brière F
J Leukoc Biol; 2005 Oct; 78(4):954-66. PubMed ID: 16081597
[TBL] [Abstract][Full Text] [Related]
39. Antitumor effects of the MIG and IP-10 genes transferred with poly [D,L-2,4-diaminobutyric acid] on murine neuroblastoma.
Tominaga M; Iwashita Y; Ohta M; Shibata K; Ishio T; Ohmori N; Goto T; Sato S; Kitano S
Cancer Gene Ther; 2007 Aug; 14(8):696-705. PubMed ID: 17514193
[TBL] [Abstract][Full Text] [Related]
40. Expression of the chemokine IP-10 correlates with the accumulation of hepatic IFN-gamma and IL-18 mRNA in chronic hepatitis C but not in hepatitis B.
Mihm S; Schweyer S; Ramadori G
J Med Virol; 2003 Aug; 70(4):562-70. PubMed ID: 12794718
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
